Skip to content

A Study in Lactating Mothers and Their Newborns to Analyse the Composition of Human Milk

A Longitudinal Prospective, Observational, Cohort Study in Lactating Mothers and Their Newborns to Further Unravel the Complexity of Human Milk

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05979532
Enrollment
172
Registered
2023-08-07
Start date
2024-02-13
Completion date
2027-08-31
Last updated
2024-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Feeding, Milk, Human

Keywords

Breast Feeding, Human milk, Research, Lactation, Human Milk Oligosaccharide, HMO

Brief summary

The current longitudinal (max. 2-year) observational cohort study in 120 lactating mothers and their newborns will make it possible to explore human milk composition across different lactation stages, between different human milk groups, and in relation to maternal, perinatal, infant, and sample characteristics as well as to the microbiota of the infant.

Interventions

None listed

Sponsors

Nutricia Research
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Pregnant women in the third trimester of pregnancy (≥28 weeks) who have the intention to provide breastfeeding for at least 6 months post-partum. * Age ≥ 18 years. * Willingness to provide residual human milk. * Living in proximity of NCRU (clinical site in NL). * Dutch speaking and reading. * Freezer -18°C available. * Having mobile phone, tablet, or computer available. * Signed informed consent from the subject (pregnant woman). * Signed informed consent from the other parent and/or legally acceptable representative, of the unborn baby(s), aged ≥ 18 years.

Exclusion criteria

* Pregnant women known positive for human immunodeficiency virus (HIV), hepatitis B (HBV), or hepatitis C (HCV). * Multiple pregnancy \> 2. * Incapability of subjects to comply with study protocol as per the judgment of the site staff (e.g. fluency in local language, access to laptop/smartphone devices and internet connection required for data collection). * Women (and their unborn baby(s)) with current or intended participation in any other clinical study involving investigational or marketed products. * Employees and/or children/family members or relatives of employees of Nutricia Research or the participating site. Continuation

Design outcomes

Primary

MeasureTime frameDescription
Examples of exploratory outcome parameters in this study are the following human milk outcome parameters.at Day 3 and at Week 1.5, 4, 10, 26, 52, and 104 postpartum.Laboratory analyses of Human Milk Oligosaccharides (HMOs), proteins, amino acids, lipids, and fatty acids.
The following exploratory faecal outcome parameter will be analysed if sufficient faecal samples are collected.at Day 3 and at Week 1.5, 4, 10, 26, 52, and 104 postpartum.Laboratory analyses of Infant's faecal microbiome composition.

Countries

Netherlands

Contacts

Primary ContactDanone Nutricia Research N Research
register.clinicalresearchnutricia@danone.com+31 30 2095 000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026